-+ 0.00%
-+ 0.00%
-+ 0.00%
A Look At Cognex (CGNX) Valuation As New AI Vision Product Cycle Gains Traction
Share
Listen to the news

Cognex stock: product cycle centered on AI vision

Cognex (CGNX) has entered a fresh product cycle built around its In-Sight 3900 vision system and the OneVision AI development environment, both aimed at scaling machine vision across high volume manufacturing.

For you as an investor, the key angle is how this combined hardware and software stack could influence Cognex's role in factory automation, where reliable inspection and ease of deployment often play a role in customer decisions alongside pure performance.

See our latest analysis for Cognex.

Cognex's recent launch of the In-Sight 3900 and general availability of OneVision comes after a strong run, with the stock delivering a 67.63% year to date share price return and a 100.86% total shareholder return over the past year. However, the 1 week share price return is down 7.96%, hinting that shorter term momentum has cooled compared with its longer term trend.

If AI driven automation is on your radar, it can also be useful to see what else is moving in this space by reviewing 32 robotics and automation stocks

After a 101% total return over the past year, a value score of 2 and a share price sitting below the average analyst target, the key question is whether Cognex still offers upside or if markets already price in future growth.

Most Popular Narrative: 5.6% Undervalued

At a last close of $61.91 versus a most-followed fair value of $65.60, the current price sits slightly below what that narrative implies.

Accelerating adoption of AI-powered vision solutions (as seen with OneVision and the shift to cloud-based, scalable deployment) positions Cognex to upsell higher-value systems and increase average selling prices, supporting higher revenue and gross margin expansion.

Read the complete narrative.

Curious what kind of revenue run rate and margin profile sits behind that price tag? The narrative leans on faster earnings growth, richer profitability and a demanding future earnings multiple. The exact mix of those ingredients is where the story gets interesting.

Result: Fair Value of $65.60 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this depends on Cognex defending its pricing power against hardware commoditisation and avoiding slower than expected adoption of cloud based AI tools like OneVision.

Find out about the key risks to this Cognex narrative.

Another View: Cash Flows Paint A Tougher Picture

The narrative driven fair value of $65.60 suggests mild upside, but the Simply Wall St DCF model lands in a very different place, with an estimate of $35.55. That implies Cognex is trading well above its future cash flow value, which raises a simple question for you: are earnings expectations running ahead of what the cash flows support?

Look into how the SWS DCF model arrives at its fair value.

CGNX Discounted Cash Flow as at May 2026
CGNX Discounted Cash Flow as at May 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Cognex for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 52 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With mixed signals across valuation models and sentiment, it helps to move quickly, review the underlying data, and decide what matters most to you, starting with 3 key rewards and 1 important warning sign.

Looking for more investment ideas?

If you stop with just one stock, you could miss other opportunities that fit your style, so use the Simply Wall St Screener to widen your options.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending